During the past decade, Parkinson disease (PD) has evolved from a textbook example of a mostly nonhereditary disease to a complex disorder with a well-established genetic component in a ...

The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...

Get Instant Summarized Text (Gist) Advanced AI genetics models have been applied to Parkinson's disease, identifying genetic factors in its progression and potential FDA-approved drugs for repurposing ...

Ibogaine by David Dardashti, a leading voice in the exploration of ibogaine's therapeutic potential, is closely analyzing a new study published in EMBO Reports that sheds light on the intricate ...

Scientists from the University of Rochester and other research centers have found a strong link between a widely used ...

Scientists employ deep learning to analyze and compare gene regulation across various cell types in human and chicken brains.

A breakthrough study has uncovered a hidden player in Parkinson’s disease—24-OHC, a cholesterol metabolite that fuels the ...

The npj Parkinson's Disease report uses an approach called "systems biology," which uses AI to integrate and analyze multiple different forms of information from genetic, proteomic, pharmaceutical ...

Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...

Numerous working models have been proposed to integrate the complexities of environmental, biochemical, genetic and neuropathological evidence, but a more simplistic model of PD pathogenesis ...

A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson’s disease. npj Parkinson's Disease , 2025; 11 (1) DOI: 10.1038/s41531-025-00870-y Cite This ...